Cargando…
N1-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor Agents
Inhibition of phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP) with small molecule inhibitors leads to apoptosis in tumor cells. Inhibitors that target both SHIP1 and SHIP2 (pan-SHIP1/2 inhibitors) may have benefits in these areas since paralog compensation is not possible when both SHI...
Autores principales: | Fernandes, Sandra, Meyer, Shea T., Shah, Jigisha P., Adhikari, Arijit A., Kerr, William G., Chisholm, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738565/ https://www.ncbi.nlm.nih.gov/pubmed/36500543 http://dx.doi.org/10.3390/molecules27238451 |
Ejemplares similares
-
Targeting SHIP1 and SHIP2 in Cancer
por: Pedicone, Chiara, et al.
Publicado: (2021) -
Obesity control by SHIP inhibition requires pan-paralog inhibition and an intact eosinophil compartment
por: Fernandes, Sandra, et al.
Publicado: (2023) -
LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism
por: Sudan, Raki, et al.
Publicado: (2022) -
Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents
por: Simonetti, Giorgia, et al.
Publicado: (2021) -
Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microglia
por: Pedicone, Chiara, et al.
Publicado: (2022)